BTG (BTG)

Sector: Pharma and Biotech     Index: FTSE 250
0.38%
2.50p
655.50p
11:05 29/07/16
655.50p
11:05 29/07/16
DAILY VARIATION
0.38%
2.50p
VOLUME
135,730
REAL TIME BATS
655.50p
11:07 29/07/16
0.23%
1.50p
DATA
52 Week High
728.00p
52 Week Low
520.50p
Shares Issued
383.00m
Market Cap
£2,510.55m
RiskGrade
n/a
Beta
0.72
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 12.6% 18.9%
ROCE 27.0%
Latest F'cast
P/E 29.8 29.4
PEG 0.8 3.5
Pr/Revenue 5.6 4.7
Pr/Book 3.0
Latest F'cast
Revenue 21.7% 1.5%
PBT 115.4% n/a
EPS 39.5% -15.5%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2012-03-31 197.00 23.00 11.40p 29.3 0.0 1,040% n/a 0.0%
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%
2016-03-31 447.50 57.50 21.90p 28.4 0.7 39% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-03-31 531.34 100.48 23.62p 29.4 3.7 8% 0.00p 0.0%
2018-03-31 623.49 142.75 31.03p 21.9 0.7 31% 0.00p 0.0%

Regulatory News

slide to see more
Directorate Change 27-Jul-16 07:05
Holding(s) in Company 26-Jul-16 15:42
Director/PDMR Shareholding 21-Jul-16 17:05

Newspaper Links

No results found
No results found